Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.85B | 6.90%8.18B | 3.45%30.41B | 2.84%7.3B | -0.42%7.65B | -17.68%29.4B | -15.02%7.65B | -17.49%6.96B | -18.50%7.1B | -19.60%7.69B |
| Cost of revenue | 3.38B | 14.87%5.71B | 6.13%20.43B | 5.53%4.94B | -1.25%4.97B | -15.88%19.25B | -16.86%4.99B | -14.79%4.54B | -14.63%4.69B | -17.00%5.03B |
| Gross profit | 1.47B | -7.87%2.47B | -1.64%9.98B | -2.32%2.36B | 1.13%2.68B | -20.87%10.15B | -11.27%2.66B | -22.14%2.42B | -25.08%2.42B | -24.10%2.65B |
| Operating expense | 1.27B | 3.51%1.42B | 18.38%5.82B | 24.43%1.48B | 17.54%1.37B | 7.47%4.92B | 10.85%1.3B | 12.18%1.27B | 4.49%1.19B | 2.29%1.16B |
| Operating profit | 196M | -19.70%1.06B | -20.46%4.16B | -28.13%884M | -11.69%1.32B | -36.60%5.23B | -25.44%1.36B | -41.84%1.15B | -41.15%1.23B | -36.83%1.49B |
| Net non-operating interest income (expenses) | ||||||||||
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -66M | -617.65%-88M | 111.32%6M | 65.38%-9M | 342.86%17M | -180.30%-53M | -1,700.00%-18M | -300.00%-2M | -2,500.00%-26M | -110.45%-7M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 356M | 29,950.00%601M | 101.40%2M | 0 | 128.57%2M | -143M | -136M | -1M | 1M | -7M |
| Less:Other special charges | ---379M | ---600M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --23M | 50.00%-1M | -101.40%-2M | --0 | -128.57%-2M | --143M | --136M | --1M | ---1M | --7M |
| Other non-operating income (expenses) | 7M | -20.00%4M | -688.89%-53M | -66.67%1M | 66.67%5M | 80.00%9M | -400.00%-3M | 200.00%6M | 250.00%3M | -25.00%3M |
| Income before tax | 533M | 17.31%1.57B | -18.39%4.11B | -27.39%875M | -9.34%1.34B | -39.40%5.04B | -34.01%1.21B | -41.68%1.15B | -42.32%1.21B | -39.10%1.48B |
| Income tax | 125M | 21.55%519M | -23.29%1.26B | -26.86%275M | -6.36%427M | -34.74%1.64B | -10.39%483M | -44.63%325M | -38.66%376M | -41.09%456M |
| Net income | 409M | 15.33%1.05B | -16.03%2.86B | -27.74%599M | -10.58%913M | -41.44%3.4B | -43.94%722M | -40.39%828M | -43.83%829M | -38.23%1.02B |
| Net income continuous operations | --408M | 15.33%1.05B | -16.02%2.86B | -27.62%600M | -10.67%913M | -41.42%3.4B | -43.90%722M | -40.43%828M | -43.83%829M | -38.17%1.02B |
| Noncontrolling interests | 0 | |||||||||
| Net income attributable to the company | 409M | 15.33%1.05B | -16.03%2.86B | -27.74%599M | -10.58%913M | -41.44%3.4B | -43.94%722M | -40.39%828M | -43.83%829M | -38.23%1.02B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 409M | 15.33%1.05B | -16.03%2.86B | -27.74%599M | -10.58%913M | -41.44%3.4B | -43.94%722M | -40.39%828M | -43.83%829M | -38.23%1.02B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 18.84 | 72.15%48.65 | 7.68%113.24 | -5.50%24.22 | -10.57%28.26 | -41.45%105.16 | -43.90%22.34 | -40.43%25.59 | -43.87%25.63 | -38.23%31.6 |
| Diluted earnings per share | 18.84 | 72.15%48.65 | 7.69%113.24 | -5.50%24.22 | -10.54%28.26 | -41.43%105.15 | -43.88%22.34 | -40.41%25.59 | -43.84%25.63 | -38.22%31.59 |
| Dividend per share | 0 | 0 | 7.55%57 | 0.00%25 | 0 | -5.36%53 | -3.45%28 | 0 | -7.41%25 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |